Thomas Deuel

Thomas Deuel

President at
Edward R. Mallinckrodt Foundation
91 year
Consumer Services
Health Technology
Commercial Services

Profile

Dr. Thomas F.
Deuel
, MD, is Independent Director at Enzon Pharmaceuticals, Inc., a Director-Vascular Biology Affinity Group at The Scripps Research Institute, a Professor-Emeritus at Harvard Medical School, President at Edward R.
Mallinckrodt Foundation, and a Member at Institute of Medicine.
He is on the Board of Directors at Enzon Pharmaceuticals, Inc. Dr. Deuel also served on the board at ImClone Systems, Inc. and Beth Israel Hospital.
Dr. Deuel received his undergraduate degree from Princeton University and a doctorate degree from Columbia University.

Thomas Deuel active positions

CompaniesPositionStart
Corporate Officer/Principal 2002-01-31
Edward R. Mallinckrodt Foundation
President -
Corporate Officer/Principal 1997-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Thomas Deuel

CompaniesPositionEnd
Director/Board Member 2013-10-21
Director/Board Member 2008-11-23
Corporate Officer/Principal 2001-12-31
See the detail of Thomas Deuel's experience

Training of Thomas Deuel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Edward R. Mallinckrodt Foundation

Consumer Services